Key Events This Week
27 Jul: Stock opens at Rs.681.50, up 1.20% amid positive market sentiment
28 Jul: Technical momentum shifts amid mixed signals; stock rises to Rs.688.85 (+1.08%)
29 Jul: Upgrade to Hold rating on improved fundamentals; stock surges 2.18% to Rs.703.90
30 Jul: Profit-taking leads to 3.00% decline, closing at Rs.682.75
31 Jul: Week closes at Rs.681.75, down 0.15% on the day

Nephrocare Health Services Ltd Upgraded to Hold on Technical and Financial Improvements
2026-07-29 08:40:11Nephrocare Health Services Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and steady financial performance. The company’s technical trend has shifted to mildly bullish, supported by positive quarterly results and a net-debt free balance sheet, although valuation concerns and institutional investor participation remain key considerations for investors.
Read full news article
Nephrocare Health Services Ltd Shows Technical Momentum Shift Amid Strong Returns
2026-07-29 08:04:48Nephrocare Health Services Ltd has shifted from a sideways to a mildly bullish technical trend, supported by improving momentum indicators and a recent upgrade in its Mojo Grade from Sell to Hold. The stock’s price momentum, bolstered by positive signals from Bollinger Bands and moving averages, suggests cautious optimism for investors amid a strong year-to-date return of 46.8% compared to the Sensex’s decline of 9.9%.
Read full news article
Nephrocare Health Services Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-07-28 08:06:44Nephrocare Health Services Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish trend to a sideways consolidation phase. Despite a recent upgrade in price action, key technical indicators present a mixed picture, reflecting both cautious optimism and underlying challenges for this small-cap healthcare services stock.
Read full news articleNephrocare Health Services Ltd Gains 5.95%: 3 Key Factors Driving the Week
2026-07-25 09:00:55
Key Events This Week
20 Jul: Stock opens at Rs.631.15, down 0.71%
22 Jul: Intraday high surge of 7.74% to Rs.673.50
23 Jul: Downgrade to Sell rating amid technical weakness
24 Jul: Stock closes week at Rs.673.45, down 0.68% on day

Nephrocare Health Services Ltd Downgraded to Sell Amid Technical Weakness and Valuation Concerns
2026-07-23 08:34:51Nephrocare Health Services Ltd, a small-cap player in the healthcare services sector, has seen its investment rating downgraded from Hold to Sell as of 22 July 2026. This revision reflects a combination of deteriorating technical indicators, expensive valuation metrics, and cautious financial trend assessments despite recent positive quarterly results. The company’s Mojo Score has declined to 41.0, signalling increased risk for investors amid shifting market dynamics.
Read full news article
Nephrocare Health Services Ltd Sees Mixed Technical Signals Amid Price Momentum Shift
2026-07-23 08:05:38Nephrocare Health Services Ltd has experienced a notable shift in its technical parameters, moving from a mildly bullish to a mildly bearish trend. Despite a strong one-week price gain of 7.74%, the company’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and volume-based metrics. This analysis delves into the recent price momentum, technical indicator readings, and broader market context to provide a comprehensive view for investors.
Read full news article
Nephrocare Health Services Ltd Surges 7.1% to Day's High of Rs 678 — Outperforms Sector by 9 Percentage Points
2026-07-22 14:47:33The Sensex declined sharply by 0.98% on 22 Jul 2026, while Nephrocare Health Services Ltd surged 7.1%, marking a 9-percentage-point outperformance over its Healthcare Services sector. This strong single-session gain rewrites the short-term narrative for the stock, which reached an intraday high of Rs 678, up 8.46% from the previous close.
Read full news articleAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
24-Jul-2026 | Source : BSEPursuant to Regulation 30 of the SEBI Listing Regulations we hereby inform you that the Company has scheduled an Investor Result Conference Call on Wednesday 12th August 2026 at 10:00 A.M IST to discuss the Unaudited Financial Results of the Company for the quarter ended 30th June 2026. A copy of the invitation is also attached for your information
Board Meeting Intimation for The Company Has Informed BSE That The Meeting Of The Board Of Directors Is Scheduled On 11/08/2026 Inter Alia To Consider And Approve The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter E
24-Jul-2026 | Source : BSENephrocare Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11-08-2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2026.
Announcement under Regulation 30 (LODR)-Newspaper Publication
17-Jul-2026 | Source : BSENewspaper Publication regarding Notice on 17th Annual General Meeting and information on remote e-voting.
Corporate Actions
11 Aug 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available







